Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02435433 |
|---|---|
| Brief Title: | A Study of Ramucirumab (LY3009806) Versus Placebo in Participants With Hepatocellular Carcinoma and Elevated Baseline Alpha-Fetoprotein (REACH-2) |
| First Submitted : | May 1, 2015 |
| First Submitted that Met QC Criteria : | May 1, 2015 |
| First Posted : | May 6, 2015 (Estimate) |
| Results First Submitted : | April 8, 2019 |
| Results First Submitted that Met QC Criteria : | April 25, 2019 |
| Results First Posted : | May 17, 2019 |
| Last Update Submitted that Met QC Criteria : | December 22, 2022 |
| Last Update Posted : | January 20, 2023 |